Academic Journal
Q2Journal of Clinical and Translational Endocrinology
About Journal of Clinical and Translational Endocrinology
About Journal of Clinical and Translational Endocrinology
Journal of Clinical and Translational Endocrinology is a peer-reviewed scholarly journal published by Elsevier B.V. (Netherlands). It focuses on Q2. Publication coverage spans 2014-2026.
Key indicators: ISSN 2214-6237; H-index 36.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (36): 36 articles have each received at least 36 citations, indicating growing recognition.
Publishing in Journal of Clinical and Translational Endocrinology
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Scope fit: Confirm your research aligns with Q2. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Journal of Clinical and Translational Endocrinology?
2214-6237.
Who publishes Journal of Clinical and Translational Endocrinology?
Elsevier B.V..
What are Journal of Clinical and Translational Endocrinology's metrics?
H-index 36.
Is Journal of Clinical and Translational Endocrinology peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Diabetes Management and Research; Diabetes, Cardiovascular Risks, and Lipoproteins; Cystic Fibrosis Research Advances; Diabetes Management and Education; Diabetes Treatment and Management; Thyroid Disorders and Treatments.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Determinants, implementation strategies, and mechanisms of the 4T Program
Ming Yeh Lee, Nicole Rioles, Franziska K. Bishop, Susan Thapa et al.
2026-11 · DOI: 10.1016/j.jcte.2026.100454Using technology to address disparities and promote healthcare equity in Type 1 Diabetes (EquiT1D) A nonrandomized clinical trial investigating solutions to low technology use
Elizabeth A. Murphy, Wen Wan, Neda Laiteerapong, Monica E. Peek et al.
2026-11 · DOI: 10.1016/j.jcte.2026.1004536 weeks of fartlek-style endurance training does not alter physiological responses to mild cold exposure but attenuates the cold-induced plasma noradrenaline response: A randomized, matched control trial
Alexander Braunsperger, Lara Becker, David P. Camargo, Sidney Radsak et al.
2026-11 · DOI: 10.1016/j.jcte.2026.100455Growth hormone-releasing hormone, growth hormone, and neuroendocrine tumors
Maham Shahid, Christian A. Koch
2026-11 · DOI: 10.1016/j.jcte.2026.100458High plasma levels of soluble triggering receptor expressed on Myeloid Cells 2 were associated with depression in patients with newly diagnosed type 2 diabetes mellitus
Eva O. Melin, Mona Landin-Olsson, Magnus Hillman
2026-11 · DOI: 10.1016/j.jcte.2026.100457Post-exercise hypoglycaemia in adults with cystic fibrosis compared to healthy control adults
Tiffany J. Dwyer, Yuankai Gu, Ruth Dentice, Molly Cocks et al.
2026-11 · DOI: 10.1016/j.jcte.2026.100456Change in circulating irisin level and its association with lipid metabolism after exenatide treatment in patients with type 2 diabetes mellitus
Yuting Gao, Xiaoyu Hong, Kun Yang, Yunyi Le et al.
2026-08 · DOI: 10.1016/j.jcte.2026.100447Thyroid cancer and double-strand DNA break repair: The potential role of the MRN complex pathogenic variants
Sriram Gubbi, Vivek Moorthy, Ashna Grover, Deema Al-Souri et al.
2026-08 · DOI: 10.1016/j.jcte.2026.100449Prevalence of overweight and obesity in a South Texas cystic fibrosis center
Radhika Pillai, Hussein Zaitoon, Wouter Koek, Kay Vavrina et al.
2026-08 · DOI: 10.1016/j.jcte.2026.100445Impact of gender-affirming hormone therapy on dry eye
Keith E. Arnold, Michael J. Foster, Tomasz A. Tabernacki, Chase A. Turner et al.
2026-08 · DOI: 10.1016/j.jcte.2026.100451Temporal changes in circulating miRNAs following gestational diabetes diagnosis: a pilot longitudinal study
Ying Gu, Yu Chen, Jingyang Li, Lingli Hu et al.
2026-08 · DOI: 10.1016/j.jcte.2026.100448Transition to adult diabetes care for young adults with type 2 diabetes: Challenge and opportunity
Giovanna F. Klimovitsky, Sandy C. Liu, Anne E. Bantle, Tasma Harindhanavudhi et al.
2026-08 · DOI: 10.1016/j.jcte.2026.100446Interaction between sleep timing and excessive daytime sleepiness in relation to metabolic syndrome among U.S. adults
Kunming Bao, Xiaozhen Chen, Dongjun Bao, Zihao Li et al.
2026-07 · DOI: 10.1016/j.jcte.2026.100450Changes in uric acid metabolism and associated plasma proteomics during sex hormone therapy
Sarah A. van Eeghen, Danii L.S. Suijk, Laura L. Pyle, Phoom Narongkiatikhun et al.
2026-05 · DOI: 10.1016/j.jcte.2026.100434Urinary neutrophil Gelatinase–Associated lipocalin as an early and reliable biomarker of diabetic nephropathy in type 2 diabetes mellitus
Elham Yousief, Ikram Hassan Adam, Tarek Abdelaziem Ramzy, Ahmed Laymouna et al.
2026-05 · DOI: 10.1016/j.jcte.2026.100441Erratum to “Remnant cholesterol inflammatory index and MASLD in U.S. adults: mediation role of triglyceride-glucose index”. [Endocrinology 43 (2026) 100427
Qiqi Hang, Ting Xu, Jiajie Guo, Ruixuan Li et al.
2026-05 · DOI: 10.1016/j.jcte.2026.100430Somatic genomic profiling reveals clinically relevant heterogeneity in RAS-mutant sporadic medullary thyroid carcinoma
Edoardo Ruggeri, Simona Censi, Loris Bertazza, Andrea Benetti et al.
2026-05 · DOI: 10.1016/j.jcte.2026.100442Suboptimal osteoporosis screening rates persist in patients on long-term glucocorticoid therapy: current experience within an academic health system
Nolawit Tesfaye, Susanne U. Trost, Rebecca L. Freese, Tasma Harindhanavudhi et al.
2026-05 · DOI: 10.1016/j.jcte.2026.100439Lipid metabolic dysregulation in diabetic kidney disease: mechanisms, cellular impact, and therapeutic strategies
You Wang, Lijia Wu, Xincui Bao, Jing Yang et al.
2026-05 · DOI: 10.1016/j.jcte.2026.100436Effect of temperature and preservative selection on C-peptide degradation in randomly voided urine
Eli H. Hagedorn, Cameron R. Rostron, Anthony Acton, Mallory Oswalt et al.
2026-05 · DOI: 10.1016/j.jcte.2026.100438Reviews
Community Reviews
Version History
October 9, 2026 at 8:31 pm
September 25, 2026